Outcomes with Ventricular Assist Device Therapy for Advanced Heart Failure in North Macedonia: First Annual Report
DOI:
https://doi.org/10.1532/hsf.3025Keywords:
Chronic Heart Failure, Mechanical Circulatory Support, Left Ventricular Assist Device, quality-of-lifeAbstract
Introduction: Mechanical circulatory support by a continuous-flow ventricular assist device (VAD) improves survival and quality of life in selected patients with advanced heart failure. Developing countries have been struggling to construct a contemporary and effective health care system to manage advanced heart failure. This observation represents the first annual report on clinical outcomes with VAD for patients with advanced heart failure in the Republic of North Macedonia.
Methods: Data from all patients with VAD implantations between November 2018 and December 2019 were collected. The etiology of the heart failure was dilated cardiomyopathy in 4 patients (57%), ischemic cardiomyopathy in 2 (28%), and hypertrophic cardiomyopathy in 1 (14%). The primary outcome was survival; secondary outcomes included adverse events defined according to the Interagency Registry for Mechanically Assisted Circulatory Support.
Results: A total of 7 patients (85% males, median age 56 years) received a VAD; 5 of them received left VAD, and the remaining 2 received biventricular VAD. There were no deaths. Observed morbidity during a mean follow-up of 216 days included 3 bleeding events in 1 patient, 2 patients with superficial driveline infection, and 1 minor stroke and a pump thrombosis, which were treated with VAD exchange. Significant improvement in quality of life, as assessed by the Kansas City Cardiomyopathy Questionnaire and the Functional Independence Measure™ instrument, was seen with all patients.
Conclusions: Our results demonstrate a successful initiation of the VAD program in the Republic of North Macedonia. Proper training of a dedicated HF team supports the reproducibility of this treatment in developing countries.
References
Acharya D, Loyaga-Rendon R, Morgan CJ, et al. 2017INTERMACS analysis of stroke during support with continuous-flow left ventricular assist devices: Risk factors and outcomes. JACC Heart Fail 5:703-711.
Birks EJ. 2017. Stopping LVAD bleeding: A piece of the puzzle. Circ Res 121:902-904.
Cooney MT, Selmer A, Lindman A, et al. 2016. Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiolog 23:1093-1103.
Fiedler RC, Granger CV. The functional independence measure: A measurement of disability and medical rehabilitation. In: Chino N, Melvin JL, eds. Functional Evaluation of Stroke Patients. Tokyo: Springer; 1996:75-92.
Goldstein DJ, John R, Salerno C, et al. 2013. Algorithm for the diagnosis and management of suspected pump thrombosis. J Heart Lung Transplant 32:667-670.
Goldstein DJ, Meyns B, Xie R, et al. 2019. Third annual report from the ISHLT mechanically assisted circulatory support registry: A comparison of centrifugal and axial continuous-flow left ventricular assist devices. J Heart Lung Transplant 38;352-362.
Guha A, Eshelbrenner CL, Richards DM, Monsour HP Jr. 2015. Gastrointestinal bleeding after continuous-flow left ventricular device implantation: Review of pathophysiology and management. Methodist Debakey Cardiovasc J 11:18-23.
Gurvits GE, Fradkov E. 2017. Bleeding with the artificial heart: Gastrointestinal hemorrhage in CF-LVAD patients. World J Gastroenterol 23:3945-3953.
Kormos RL, Cowger J, Pagani FD, et al. 2019. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes and scientific partnerships. J Heart Lung Transplant 38:114-126.
Lang T, Altman D. Basic statistical reporting for articles published in clinical medical journals: The SAMPL Guidelines. In: Smart P, Maisonneuve H, Polderman A, eds. Science Editors’ Handbook. Exeter, UK: European Association of Science Editors; 2013.
Lavee J, Mulzer J, Krabatsch T, Marasco S, McGiffin D, Garbade J, Schmitto JD, Zimpfer D, Potapov EV. 2018. An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems. J Heart Lung Transplant 37:1399-1402.
Luc JGY, Tchantchaleishvili V, Phan K, Dunlay SM, Maltais S, Stulak JM. 2019. Medical therapy as compared to surgical device exchange for left ventricular device thrombosis. A systematic review and meta-analysis. ASAIO J 65:307-317.
Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S, et al. 2015. The Registry of the International Society for Heart and Lung Transplantation: Thirty-second official adult heart transplantation report—2015; focus theme: early graft failure. J Heart Lung Transplant 34:1244–54.
Maclver J, Ross HJ. 2012. Quality of life and left ventricular device support. Circulation 126:866-874.
Michaels A, Cowger J. 2019. Patient selection for destination LVAD therapy: Predicting success in the short and long term. Current Heart Fail Rep 16:140-149.
Mitrev Z, Anguseva T, Vasileva A, Hristov N, Risteski P. 2002. Transplantation or alternative surgical treatment of patients with ischemic dilative cardiomyopathy and aneurysmatic dilation of the left ventricular cavity. Int J Artif Organs 25(4):321-326.
Nestorovic E, Schmitto JD, Kushwaha SS, et al. 2018. Successful establishment of a left ventricular assist device program in an emerging country: One year experience. J Thoracic Dis 10(suppl 15):S1743-S1750.
Pagani FD, Miller LW, Russell SD, et al. 2009. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol 21:54:312-321.
Ponikowski P, Voors AA, Anker SD, et al. 2016. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129-2200.
Popov AF, Hosseini MT, Zych B, et al. 2012. Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure. Ann Thoracic Surg 93:810-815.
Radwan M, Risteski P, Hoffmann R, Popov AF. 2018. Repeat left ventricular device exchange with inflow or outflow correction for recurrent pump thrombosis and cerebral haemorrhage through limited incisions. Eur J Cardiothorac Surg 54:781-783.
Yalcin YC, Muslem R, Veen KM, et al. 2020. Impact of continuous flow left ventricular assist device therapy on chronic kidney disease: A longitudinal multicenter study. J Card Fail 26:333-341.
